Cargando…
Augmentation of NAD(+) by Dunnione Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis in Mice
BACKGROUND: Dunnione has anti-inflammatory properties arising from its ability to alter the ratio of NAD(+)/NADH through NAD(P)H quinone oxidoreductase 1 (NQO1) enzymatic action, followed by subsequent inhibition of NF-κB and inflammatory cytokines. Psoriasis is a chronic, inflammatory skin disorder...
Autores principales: | Lee, Seung Hoon, Kim, Hyung-Jin, Oh, Gi-Su, Lee, Su-Bin, Khadka, Dipendra, Cao, Wal, Choe, Seong-Kyu, Shim, Hyeok, Kim, Chang-Deok, Kwak, Tae Hwan, So, Hong-Seob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386739/ https://www.ncbi.nlm.nih.gov/pubmed/35991005 http://dx.doi.org/10.2147/JIR.S372543 |
Ejemplares similares
-
NAD(+) augmentation ameliorates acute pancreatitis through regulation of inflammasome signalling
por: Shen, AiHua, et al.
Publicado: (2017) -
Augmentation of cellular NAD(+) by NQO1 enzymatic action improves age‐related hearing impairment
por: Kim, Hyung‐Jin, et al.
Publicado: (2019) -
Modulation of Cellular NAD(+) Attenuates Cancer-Associated Hypercoagulability and Thrombosis via the Inhibition of Tissue Factor and Formation of Neutrophil Extracellular Traps
por: Cao, Wa, et al.
Publicado: (2021) -
Inhibitory effects of a β-dunnione compound MB12662 on gastric secretion and ulcers
por: Jo, In-Geun, et al.
Publicado: (2013) -
Antimalarial Properties of Dunnione Derivatives as NQO2 Substrates
por: Chhour, Monivan, et al.
Publicado: (2019)